The object
Eileen Ingham co-developed decellularisation platform technologies that wash cells and DNA from donor tissue to create biological scaffolds for repair. Her University of Leeds profile identifies her as a patent-family inventor and academic founder of the Tissue Regenix spin-out commercializing the scaffold technology for musculoskeletal and cardiovascular applications.
What Eileen did
Co-developed and licensed decellularisation platform technologies that produce acellular tissue-repair scaffolds.
Why it matters
The process converts donor tissue into implantable repair scaffolds designed to avoid the immune rejection caused by cellular material.
Living-status check
Leeds current 2026 profile lists Ingham as Emeritus Professor and describes active research on acellular scaffolds for tissue repair and regeneration.